Providers must administer a urine drug test and document results during the subacute phase and repeat at intervals according to the worker's risk category as described in the agency medical directors' group's guideline if prescribing chronic opioid therapy. The department or self-insurer may deny additional payment for urine drug testing when opioid coverage is denied.